Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Covalon Technologies Ltd
V.COV
Alternate Symbol(s):
CVALF
Healthcare
Medical Instruments & Supplies
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold...
under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:COV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
(153)
•••
prophetoffactz
X
Comment by
prophetoffactz
on Jan 26, 2023 9:38am
RE:4Q & Yearend fiscal '22
If you listen to the conference call they mentioned cash at the end of the quarter and cash now and there was little difference. The cash at the end of the quarter was as at Steptember 30 when the
...more
(4)
•••
mba123ccu
X
Post by
mba123ccu
on Jan 25, 2023 10:26pm
4Q & Yearend fiscal '22
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes In spite of a clean balance sheet, no debt and lots of cash not a good 4Q but IMO
...more
(9)
•••
bronkrdr
X
Comment by
bronkrdr
on Jan 16, 2023 10:51am
RE:4th quarter results
Good question. Someone had to get out in hurray this morning and gave away the cow.
(5)
•••
dave24
X
Post by
dave24
on Jan 12, 2023 9:54am
4th quarter results
I was expecting to see the 4th quarter results in early December. Any thoughts?
(4)
•••
FactualOne
X
Post by
FactualOne
on Dec 08, 2022 12:19pm
Link to Covalon Planet Microcap Covalon Presentation
https://www.webcaster4.com/Player/Index?webcastId=47186&g=e6cba002-f3a9-4c61-b24f-926f37d89b8e&uid=6667164&sid=
(9)
•••
bronkrdr
X
Comment by
bronkrdr
on Dec 06, 2022 1:46pm
RE:Summary
Not sure what you were posting.
(17)
•••
ARIMA11
X
Post by
ARIMA11
on Dec 02, 2022 10:58am
Summary
https://www.rally-co.ca/post/cov-v-returns
(4)
•••
FactualOne
X
Post by
FactualOne
on Nov 29, 2022 11:06am
Covalon - Planet Microcap Virtual Conf. 12.8.22 8:30 am est
https://www.accesswire.com/729266/Covalonto-Present-at-the-Planet-MicroCap-Investor-Showcase-VIRTUAL-2022-on-Wednesday-December-7-2022
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 08, 2022 10:02am
New Press Release - Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections
Amongst a climbing Central Line Associated Blood Stream Infection ("CLABSI") rate across the United States, Covalon is releasing new digital resources focused on the role of technology to strengthen and reinforce infection prevention practices.MISSISSAUGA, ON, Nov. 8, 2022 /PRNewswire/ - Covalon...
read article.
(9)
•••
bronkrdr
X
Comment by
bronkrdr
on Nov 01, 2022 11:23am
RE:RE:Features and Benefits is Outstanding!
There's a testimonial that came out today from the University of Michigan that is truly inspiring.
(4)
•••
FactualOne
X
Post by
FactualOne
on Nov 01, 2022 11:22am
UofM Study PR November 1, 2022
https://www.prnewswire.com/news-releases/closing-chronic-wounds-with-collagen-powder-university-of-michigan-case-study-demonstrates-the-efficacy-of-colactive-plus-powder-in-resolving-non-healing
...more
(17)
•••
ARIMA11
X
Comment by
ARIMA11
on Oct 19, 2022 12:06pm
RE:Features and Benefits is Outstanding!
Absolutely great products but can they finally deliver on revenues? Buyback is good but its likely that other expenses are on the rise. We'll see how they fare in the next earning results.
(9)
•••
bronkrdr
X
Post by
bronkrdr
on Oct 17, 2022 11:09am
Features and Benefits is Outstanding!
Infection rates steadily declined over the course of the project, reaching 0 infections after 1 year The transparency of SurgiClear reduced the number of dressing changes, in turn reducing
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 11, 2022 12:00pm
New Press Release - Covalon to Participate in the American Nurses Credentialing Center Magnet Conference in Philadelphia
Visit Covalon at booth 1557 from October 13 to October 15, 2022 at the Pennsylvania Convention CenterMISSISSAUGA, ON, Oct. 11, 2022 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Despite turbulent markets this logistics company continues to grow
New Analyst Report Lifts Almonty Target Price to CDN$5.50
Mullen Group acquires company expected to generate annualized revenues of $300 million